Da: Universitätsbuchhandlung Herta Hold GmbH, Berlin, Germania
EUR 18,00
Quantità: 2 disponibili
Aggiungi al carrelloix, 362p. Hardcover. Versand aus Deutschland / We dispatch from Germany via Air Mail. Einband bestoßen, daher Mängelexemplar gestempelt, sonst sehr guter Zustand. Imperfect copy due to slightly bumped cover, apart from this in very good condition. Stamped. Stamped. Current Cancer Research. Sprache: Englisch.
Da: ThriftBooks-Atlanta, AUSTELL, GA, U.S.A.
Paperback. Condizione: Very Good. No Jacket. May have limited writing in cover pages. Pages are unmarked. ~ ThriftBooks: Read More, Spend Less.
Condizione: Brand New. New. US edition. Expediting shipping for all USA and Europe orders excluding PO Box. Excellent Customer Service.
Da: Phatpocket Limited, Waltham Abbey, HERTS, Regno Unito
EUR 119,39
Quantità: 1 disponibili
Aggiungi al carrelloCondizione: Good. Your purchase helps support Sri Lankan Children's Charity 'The Rainbow Centre'. Ex-library, so some stamps and wear, but in good overall condition. Our donations to The Rainbow Centre have helped provide an education and a safe haven to hundreds of children who live in appalling conditions.
Da: GreatBookPrices, Columbia, MD, U.S.A.
EUR 137,54
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New.
Da: PBShop.store US, Wood Dale, IL, U.S.A.
HRD. Condizione: New. New Book. Shipped from UK. Established seller since 2000.
Da: PBShop.store UK, Fairford, GLOS, Regno Unito
EUR 131,64
Quantità: 1 disponibili
Aggiungi al carrelloHRD. Condizione: New. New Book. Shipped from UK. Established seller since 2000.
Da: GreatBookPricesUK, Woodford Green, Regno Unito
EUR 130,41
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New.
Da: Speedyhen LLC, Hialeah, FL, U.S.A.
Condizione: NEW.
Da: GreatBookPrices, Columbia, MD, U.S.A.
EUR 149,99
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: As New. Unread book in perfect condition.
Da: Chiron Media, Wallingford, Regno Unito
EUR 137,99
Quantità: 1 disponibili
Aggiungi al carrelloHardcover. Condizione: New.
Da: Ria Christie Collections, Uxbridge, Regno Unito
EUR 144,41
Quantità: 1 disponibili
Aggiungi al carrelloCondizione: New. In.
Da: Speedyhen, Hertfordshire, Regno Unito
EUR 116,80
Quantità: 1 disponibili
Aggiungi al carrelloCondizione: NEW.
Da: Ria Christie Collections, Uxbridge, Regno Unito
EUR 152,03
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New. In.
Da: GreatBookPricesUK, Woodford Green, Regno Unito
EUR 149,06
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: As New. Unread book in perfect condition.
Da: Kennys Bookshop and Art Galleries Ltd., Galway, GY, Irlanda
EUR 159,37
Quantità: 1 disponibili
Aggiungi al carrelloCondizione: New. 2018. Hardcover. . . . . .
Da: Ria Christie Collections, Uxbridge, Regno Unito
EUR 164,24
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New. In.
Lingua: Inglese
Editore: Springer International Publishing AG, CH, 2018
ISBN 10: 3319787616 ISBN 13: 9783319787619
Da: Rarewaves.com USA, London, LONDO, Regno Unito
EUR 189,62
Quantità: 1 disponibili
Aggiungi al carrelloHardback. Condizione: New. Second Edition 2018.
Da: Revaluation Books, Exeter, Regno Unito
EUR 171,65
Quantità: 1 disponibili
Aggiungi al carrelloHardcover. Condizione: Brand New. 2nd edition. 636 pages. 9.25x6.10x1.46 inches. In Stock.
Condizione: New. Softcover reprint of the original 2nd ed. 2018 edition NO-PA16APR2015-KAP.
Lingua: Inglese
Editore: Springer International Publishing, 2018
ISBN 10: 3319787616 ISBN 13: 9783319787619
Da: moluna, Greven, Germania
EUR 150,48
Quantità: 1 disponibili
Aggiungi al carrelloGebunden. Condizione: New. Summarize the unique pathobiology of head and neck cancersAddresses signaling pathways and individual proteins that are important in causing or supporting the aggressive nature of head and neck cancerDiscusses the sequencing and epigen.
Condizione: New. 2018. Hardcover. . . . . . Books ship from the US and Ireland.
Da: Kennys Bookshop and Art Galleries Ltd., Galway, GY, Irlanda
EUR 199,31
Quantità: 15 disponibili
Aggiungi al carrelloCondizione: New. 2018. Paperback. . . . . .
Lingua: Inglese
Editore: Springer Nature Switzerland, 2018
ISBN 10: 3030087794 ISBN 13: 9783030087791
Da: preigu, Osnabrück, Germania
EUR 140,00
Quantità: 5 disponibili
Aggiungi al carrelloTaschenbuch. Condizione: Neu. Molecular Determinants of Head and Neck Cancer | Barbara Burtness (u. a.) | Taschenbuch | vi | Englisch | 2018 | Springer Nature Switzerland | EAN 9783030087791 | Verantwortliche Person für die EU: Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu.
Da: Books Puddle, New York, NY, U.S.A.
Condizione: New.
Da: moluna, Greven, Germania
EUR 166,97
Quantità: Più di 20 disponibili
Aggiungi al carrelloKartoniert / Broschiert. Condizione: New.
Lingua: Inglese
Editore: Springer International Publishing, Springer International Publishing, 2018
ISBN 10: 3030087794 ISBN 13: 9783030087791
Da: AHA-BUCH GmbH, Einbeck, Germania
EUR 160,49
Quantità: 1 disponibili
Aggiungi al carrelloTaschenbuch. Condizione: Neu. Druck auf Anfrage Neuware - Printed after ordering - Squamous cell cancers of the head and neck (SCCHN), also known as head and neck cancers (HNC) encompass malignancies of the oral cavity, larynx, nasopharynx and pharynx, and are diagnosed in over 500,000 patients worldwide each year, accounting for 5% of all malignancies. It is estimated that approximately 50,000 patients develop head and neck cancer annually in the United States, of whom approximately 50% succumb to this cancer. For most cases of SCCHN, treatment is multimodal, often combining surgery or irradiation with chemotherapy; even successfully treated patients frequently experience durable and severe side effects. Improving cure rates and reducing chronic morbidity are urgent clinical needs for head and neck cancer. However, in contrast to cancer types such as breast or prostate that have been much studied and have well-defined biology, until recently, relatively few researchers investigated the molecular basis of HNC, making it difficult to design targeted treatments with better efficacy and less debilitating side effects. This volume will provide an overview of the factors contributing to disease pathogenesis, including the recognition of discrete molecular subtypes with distinct etiology, prognosis, and treatment response. This volume will familiarize the reader with the critical signaling pathways and oncogenic drivers for HNC. It will outline the differences between HPV-positive and HPV-negative disease, and how these differences affect treatment choice and outcome. The book will emphasize developments in the past five years, including the growing understanding of the genomic and epigenomic features of the disease based on analysis of next generation sequencing (NGS) data, and timely topics such as the analysis of HNC stem cell populations, non-coding mRNAs, and inflammatory response. It will address exciting new therapeutic approaches such as the use of immunotherapies to treat HNC patients. Overall, the book will provide the reader with current understanding of the biology and treatment of the disease, and describe timely questions that will guide future research aimed at controlling and curing this disease.
Lingua: Inglese
Editore: Springer International Publishing, Springer International Publishing, 2018
ISBN 10: 3319787616 ISBN 13: 9783319787619
Da: AHA-BUCH GmbH, Einbeck, Germania
EUR 160,49
Quantità: 1 disponibili
Aggiungi al carrelloBuch. Condizione: Neu. Druck auf Anfrage Neuware - Printed after ordering - Squamous cell cancers of the head and neck (SCCHN), also known as head and neck cancers (HNC) encompass malignancies of the oral cavity, larynx, nasopharynx and pharynx, and are diagnosed in over 500,000 patients worldwide each year, accounting for 5% of all malignancies. It is estimated that approximately 50,000 patients develop head and neck cancer annually in the United States, of whom approximately 50% succumb to this cancer. For most cases of SCCHN, treatment is multimodal, often combining surgery or irradiation with chemotherapy; even successfully treated patients frequently experience durable and severe side effects. Improving cure rates and reducing chronic morbidity are urgent clinical needs for head and neck cancer. However, in contrast to cancer types such as breast or prostate that have been much studied and have well-defined biology, until recently, relatively few researchers investigated the molecular basis of HNC, making it difficult to design targeted treatments with better efficacy and less debilitating side effects. This volume will provide an overview of the factors contributing to disease pathogenesis, including the recognition of discrete molecular subtypes with distinct etiology, prognosis, and treatment response. This volume will familiarize the reader with the critical signaling pathways and oncogenic drivers for HNC. It will outline the differences between HPV-positive and HPV-negative disease, and how these differences affect treatment choice and outcome. The book will emphasize developments in the past five years, including the growing understanding of the genomic and epigenomic features of the disease based on analysis of next generation sequencing (NGS) data, and timely topics such as the analysis of HNC stem cell populations, non-coding mRNAs, and inflammatory response. It will address exciting new therapeutic approaches such as the use of immunotherapies to treat HNC patients. Overall, the book will provide the reader with current understanding of the biology and treatment of the disease, and describe timely questions that will guide future research aimed at controlling and curing this disease.
Condizione: New. pp. 362.
Da: Buchpark, Trebbin, Germania
EUR 130,32
Quantità: 2 disponibili
Aggiungi al carrelloCondizione: Hervorragend. Zustand: Hervorragend | Seiten: 636 | Sprache: Englisch | Produktart: Bücher | Squamous cell cancers of the head and neck (SCCHN), also known as head and neck cancers (HNC) encompass malignancies of the oral cavity, larynx, nasopharynx and pharynx, and are diagnosed in over 500,000 patients worldwide each year, accounting for 5% of all malignancies. It is estimated that approximately 50,000 patients develop head and neck cancer annually in the United States, of whom approximately 50% succumb to this cancer. For most cases of SCCHN, treatment is multimodal, often combining surgery or irradiation with chemotherapy; even successfully treated patients frequently experience durable and severe side effects. Improving cure rates and reducing chronic morbidity are urgent clinical needs for head and neck cancer. However, in contrast to cancer types such as breast or prostate that have been much studied and have well-defined biology, until recently, relatively few researchers investigated the molecular basis of HNC, making it difficult to design targeted treatments with better efficacy and less debilitating side effects. This volume will provide an overview of the factors contributing to disease pathogenesis, including the recognition of discrete molecular subtypes with distinct etiology, prognosis, and treatment response. This volume will familiarize the reader with the critical signaling pathways and oncogenic drivers for HNC. It will outline the differences between HPV-positive and HPV-negative disease, and how these differences affect treatment choice and outcome. The book will emphasize developments in the past five years, including the growing understanding of the genomic and epigenomic features of the disease based on analysis of next generation sequencing (NGS) data, and timely topics such as the analysis of HNC stem cell populations, non-coding mRNAs, and inflammatory response. It will address exciting new therapeutic approaches such as the use of immunotherapies to treat HNC patients. Overall, the book will provide the reader with current understanding of the biology and treatment of the disease, and describe timely questions that will guide future research aimed at controlling and curing this disease.